Economic evaluation analysis indicated imbalance in pediatric cancer treatment

Applying economic evaluation tools, such as cost and cost-effectiveness analysis, to pediatric cancer treatments demonstrated an imbalance of tumor-directed therapy and supportive therapy evaluations, according to a recent literature review.

Read more here.